Prakiraan Saham Mother and child (MDMG)
Prediksi AI: MDMG
AI menerbitkan harga target untuk hari perdagangan berikutnya, akhir minggu, dan akhir bulan. Perubahan diukur dari harga terbaru. Ini adalah estimasi statistik, bukan saran investasi.
Harga selama 6 bulan terakhir
Premium menampilkan target harga AI untuk 1 hari, 1 minggu, dan 1 bulan untuk saham ini dan saham lainnya.
Buka Premium🔒 Rekam jejak prakiraan
Rekam jejak prakiraan — setiap prakiraan masa lalu di sebelah penutupan aktual — adalah bagian dari Premium.
Buka PremiumTentang Perusahaan Ini
Mater and Ditya is one of the leaders of the Russian private healthcare market. Founded in 2006 by obstetrician-gynecologist Mark Kurtser, the company now holds a leading position in Russia in the field of women’s and children’s health. The company’s assets include 11 high-tech hospitals, 44 clinics, and one medical university. The medical facilities specialize in a broad range of healthcare services, providing care in reproductive medicine, women’s health, and pediatrics, as well as in the treatment of socially significant diseases, including oncology and cardiology. In 2022, the company ranked second in Forbes’ “Top 20 Medical Companies – 2022” ranking, with revenue of RUB 25 billion.
